Hybrid compounds as anti-infective agents
- Autores
- Sbaraglini, Maria Laura; Talevi, Alan
- Año de publicación
- 2017
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Hybrid drugs are multi-target chimeric chemicals combining two or more drugs or pharmacophores covalently linked in a single molecule. In the field of anti-infective agents, they have been proposed as a possible solution to drug resistance issues, presumably having a broader spectrum of activity and less probability of eliciting high level resistance linked to single gene product. Although less frequently explored, they could also be useful in the treatment of frequently occurring co-infections. Here, we overview recent advances in the field of hybrid antimicrobials. Furthermore, we discuss some cutting-edge approaches to face the development of designed multi-target agents in the era of omics and big data, namely analysis of gene signatures and multitask QSAR models.
Fil: Sbaraglini, Maria Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra de Química Medicinal; Argentina
Fil: Talevi, Alan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra de Química Medicinal; Argentina - Materia
-
Anti-Infective
Antibiotic
Antifungal
Antimicrobial
Antimicrobial Resistance
Antiviral
Chimeric Molecule
Hybrid Drug
Hybrid Molecule
Multi-Target Agents
Multi-Target Drug - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/55197
Ver los metadatos del registro completo
id |
CONICETDig_355df4f1ac26c06a4e95b51aeff7f376 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/55197 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Hybrid compounds as anti-infective agentsSbaraglini, Maria LauraTalevi, AlanAnti-InfectiveAntibioticAntifungalAntimicrobialAntimicrobial ResistanceAntiviralChimeric MoleculeHybrid DrugHybrid MoleculeMulti-Target AgentsMulti-Target Drughttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Hybrid drugs are multi-target chimeric chemicals combining two or more drugs or pharmacophores covalently linked in a single molecule. In the field of anti-infective agents, they have been proposed as a possible solution to drug resistance issues, presumably having a broader spectrum of activity and less probability of eliciting high level resistance linked to single gene product. Although less frequently explored, they could also be useful in the treatment of frequently occurring co-infections. Here, we overview recent advances in the field of hybrid antimicrobials. Furthermore, we discuss some cutting-edge approaches to face the development of designed multi-target agents in the era of omics and big data, namely analysis of gene signatures and multitask QSAR models.Fil: Sbaraglini, Maria Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra de Química Medicinal; ArgentinaFil: Talevi, Alan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra de Química Medicinal; ArgentinaBentham Science Publishers2017-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/55197Sbaraglini, Maria Laura; Talevi, Alan; Hybrid compounds as anti-infective agents; Bentham Science Publishers; Current Topics in Medicinal Chemistry; 17; 9; 4-2017; 1080-10951568-02661873-4294CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.2174/1568026616666160927160912info:eu-repo/semantics/altIdentifier/url/http://www.eurekaselect.com/145866/articleinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:47:01Zoai:ri.conicet.gov.ar:11336/55197instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:47:01.347CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Hybrid compounds as anti-infective agents |
title |
Hybrid compounds as anti-infective agents |
spellingShingle |
Hybrid compounds as anti-infective agents Sbaraglini, Maria Laura Anti-Infective Antibiotic Antifungal Antimicrobial Antimicrobial Resistance Antiviral Chimeric Molecule Hybrid Drug Hybrid Molecule Multi-Target Agents Multi-Target Drug |
title_short |
Hybrid compounds as anti-infective agents |
title_full |
Hybrid compounds as anti-infective agents |
title_fullStr |
Hybrid compounds as anti-infective agents |
title_full_unstemmed |
Hybrid compounds as anti-infective agents |
title_sort |
Hybrid compounds as anti-infective agents |
dc.creator.none.fl_str_mv |
Sbaraglini, Maria Laura Talevi, Alan |
author |
Sbaraglini, Maria Laura |
author_facet |
Sbaraglini, Maria Laura Talevi, Alan |
author_role |
author |
author2 |
Talevi, Alan |
author2_role |
author |
dc.subject.none.fl_str_mv |
Anti-Infective Antibiotic Antifungal Antimicrobial Antimicrobial Resistance Antiviral Chimeric Molecule Hybrid Drug Hybrid Molecule Multi-Target Agents Multi-Target Drug |
topic |
Anti-Infective Antibiotic Antifungal Antimicrobial Antimicrobial Resistance Antiviral Chimeric Molecule Hybrid Drug Hybrid Molecule Multi-Target Agents Multi-Target Drug |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Hybrid drugs are multi-target chimeric chemicals combining two or more drugs or pharmacophores covalently linked in a single molecule. In the field of anti-infective agents, they have been proposed as a possible solution to drug resistance issues, presumably having a broader spectrum of activity and less probability of eliciting high level resistance linked to single gene product. Although less frequently explored, they could also be useful in the treatment of frequently occurring co-infections. Here, we overview recent advances in the field of hybrid antimicrobials. Furthermore, we discuss some cutting-edge approaches to face the development of designed multi-target agents in the era of omics and big data, namely analysis of gene signatures and multitask QSAR models. Fil: Sbaraglini, Maria Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra de Química Medicinal; Argentina Fil: Talevi, Alan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Ciencias Biológicas. Cátedra de Química Medicinal; Argentina |
description |
Hybrid drugs are multi-target chimeric chemicals combining two or more drugs or pharmacophores covalently linked in a single molecule. In the field of anti-infective agents, they have been proposed as a possible solution to drug resistance issues, presumably having a broader spectrum of activity and less probability of eliciting high level resistance linked to single gene product. Although less frequently explored, they could also be useful in the treatment of frequently occurring co-infections. Here, we overview recent advances in the field of hybrid antimicrobials. Furthermore, we discuss some cutting-edge approaches to face the development of designed multi-target agents in the era of omics and big data, namely analysis of gene signatures and multitask QSAR models. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/55197 Sbaraglini, Maria Laura; Talevi, Alan; Hybrid compounds as anti-infective agents; Bentham Science Publishers; Current Topics in Medicinal Chemistry; 17; 9; 4-2017; 1080-1095 1568-0266 1873-4294 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/55197 |
identifier_str_mv |
Sbaraglini, Maria Laura; Talevi, Alan; Hybrid compounds as anti-infective agents; Bentham Science Publishers; Current Topics in Medicinal Chemistry; 17; 9; 4-2017; 1080-1095 1568-0266 1873-4294 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.2174/1568026616666160927160912 info:eu-repo/semantics/altIdentifier/url/http://www.eurekaselect.com/145866/article |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Bentham Science Publishers |
publisher.none.fl_str_mv |
Bentham Science Publishers |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268831459835904 |
score |
13.13397 |